TABLE 1

Interobserver Agreement on Dichotomized DS, by Baseline Modality

I-PET/CTEoT-PET/CT
AgreementTotal (n = 465)Baseline CT only (n = 108)Baseline 18F-FDG PET or PET/CT (n = 357)P*Total (n = 457)Baseline CT only (n = 114)Baseline 18F-FDG PET or PET/CT (n = 343)P*
Positivity23.318.524.817.518.017.3
Percentage OA87.7 (84.7–90.8)87.0 (80.2–93.8)88.0 (84.4–91.5)0.79991.7 (89.0–94.3)93.9 (89.0–98.7)91.0 (87.8–94.1)0.332
Percentage PA73.7 (65.0–82.5)65.0 (41.6–88.4)75.7 (66.2–85.2)0.34776.3 (66.3–86.2)82.9 (59.2–90.8)73.9 (62.0–85.9)0.486
Percentage NA92.0 (89.1–95.0)92.0 (85.8–98.3)92.0 (88.6–95.4)0.94795.0 (92.6–97.3)96.3 (89.5–97.9)94.5 (91.7–97.4)0.605
  • DS 1–3 = negative; DS 4–5 = positive.

  • * P values of χ2 test refer to comparison of baseline CT vs. baseline PET or PET/CT.

  • Prevalence of positive scans was calculated as sum of number of scans in which both reviewers scored positively and half of scans with discrepancies divided by total number of scans.

  • Data are percentages, with 95%CIs in parentheses.